Q8BH79
Gene name |
Ano10 (Tmem16k) |
Protein name |
Anoctamin-10 |
Names |
Transmembrane protein 16K |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:102566 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8BH79
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8BH79-F1 | Predicted | AlphaFoldDB |
44 variants for Q8BH79
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs241401536 | 5 | L>S | No | EVA | |
| rs235933250 | 9 | D>G | No | EVA | |
| rs212591013 | 13 | S>N | No | EVA | |
| rs3389051906 | 15 | F>L | No | EVA | |
| rs3389083841 | 18 | L>Q | No | EVA | |
| rs33509769 | 21 | I>L | No | EVA | |
| rs230719277 | 26 | D>G | No | EVA | |
| rs3389093655 | 35 | L>F | No | EVA | |
| rs3400226106 | 77 | V>D | No | EVA | |
| rs3400866141 | 80 | L>F | No | EVA | |
| rs3389089004 | 86 | V>F | No | EVA | |
| rs3389030873 | 113 | D>E | No | EVA | |
| rs3389051957 | 139 | D>V | No | EVA | |
| rs3389093611 | 144 | P>L | No | EVA | |
| rs3413019812 | 147 | P>S | No | EVA | |
| rs3389088957 | 168 | T>A | No | EVA | |
| rs3389030875 | 170 | V>E | No | EVA | |
| rs3389093671 | 195 | Q>R | No | EVA | |
| rs3389030884 | 199 | S>N | No | EVA | |
| rs3389072221 | 201 | R>H | No | EVA | |
| rs3389085256 | 217 | Y>H | No | EVA | |
| rs3389093646 | 236 | V>A | No | EVA | |
| rs3389051934 | 245 | I>F | No | EVA | |
| rs3389051895 | 253 | W>* | No | EVA | |
| rs864287352 | 272 | W>R | No | EVA | |
| rs3400675691 | 274 | T>P | No | EVA | |
| rs3389029486 | 279 | R>M | No | EVA | |
| rs3389029406 | 285 | R>L | No | EVA | |
| rs3389085264 | 328 | F>V | No | EVA | |
| rs3389094529 | 343 | A>T | No | EVA | |
| rs3389086363 | 362 | P>L | No | EVA | |
| rs3389063839 | 385 | T>I | No | EVA | |
| rs3400226130 | 424 | K>Q | No | EVA | |
| rs3389072193 | 450 | L>H | No | EVA | |
| rs214145397 | 473 | E>D | No | EVA | |
| rs3389051969 | 474 | V>I | No | EVA | |
| rs3389094501 | 476 | T>I | No | EVA | |
| rs3389061225 | 485 | E>V | No | EVA | |
| rs3389094479 | 486 | K>S | No | EVA | |
| rs3412941821 | 579 | Q>K | No | EVA | |
| rs3389087809 | 580 | V>M | No | EVA | |
| rs3389085286 | 609 | L>V | No | EVA | |
| rs3389063807 | 626 | R>S | No | EVA | |
| rs3389093584 | 643 | V>M | No | EVA |
No associated diseases with Q8BH79
No regional properties for Q8BH79
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q8BH79 | |||
Functions
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| intracellular membrane-bounded organelle | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| calcium activated cation channel activity | Enables the calcium concentration-regulatable energy-independent passage of cations across a lipid bilayer down a concentration gradient. |
| intracellular calcium activated chloride channel activity | Enables the transmembrane transfer of chloride by a channel that opens in response to stimulus by a calcium ion or ions. Transport by a channel involves catalysis of facilitated diffusion of a solute (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel, without evidence for a carrier-mediated mechanism. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| cation transport | The directed movement of cations, atoms or small molecules with a net positive charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| chloride transport | The directed movement of chloride into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| transmembrane transport | The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MRVTLSTLDT | CESSFTPLVV | IELAQDVKDE | TKEWLKNRII | AKKKDGGAQL | LFRPLLNKYE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| KETLENQNLY | LVGASNVRLL | LGAEAVGLVK | ECTDAAMRAF | TYGTRHNFKG | FHDNNNDFLT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| MAECQFIIKH | ELENLRARDE | KMIPGYPQAK | LYPGKSLMRR | LLTSGIVTQV | FPLHDTEALK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KLEDTWYTRF | ALKYQPIDSI | RSYFGETIAL | YFGFLEYFTF | ALIPMAIIGL | PYYLFVWEDY |
| 250 | 260 | 270 | 280 | 290 | 300 |
| DKYVIFASFN | LIWSTVILEV | WKRGCANMTY | RWGTLVMKRQ | FEEPRPGFHG | VLGINSVTGR |
| 310 | 320 | 330 | 340 | 350 | 360 |
| EEPLYSSYKR | QLRIYLVSLP | FVCLCLYFSL | YVMMIYFDME | DWALSLHEDS | GSEWTSLLLY |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VPSIVYAVVI | EIMNRLYRYA | AEFLTSWENH | RLESAYQNHL | VLKVLVFNFL | NCFASLFYIA |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FVLKDMKLLR | QSLATLLITS | QILNQVVESL | LPYWLQRKYC | ARVKRKVQAL | KSEVDTTLYE |
| 490 | 500 | 510 | 520 | 530 | 540 |
| QVLLEKEMGT | YLGTFDDYLE | LFLQFGYVSL | FSCVYPLAAA | FAVLNNFTEV | NSDALKMCRV |
| 550 | 560 | 570 | 580 | 590 | 600 |
| FKRPFAEPSA | SIGVWQLAFE | TMSVISVVTN | CALIGMSPQV | NAVFPESKTD | LVLIVVAVEH |
| 610 | 620 | 630 | 640 | 650 | |
| ALLALKFILA | FAIPDKPRHI | QQKLARLEFE | SLEALKQQQM | KLVAENLKEE | YQEDGKEAT |